Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now
Read now
Guido Di Sciascio & Marco Andrea Riva. (2015) Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatric Disease and Treatment 11, pages 2635-2647.
Read now
Read now
Kiran Kumar Sayyaparaju, Heinz Grunze & Kostas N Fountoulakis. (2014) When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatric Disease and Treatment 10, pages 459-470.
Read now
Read now
Maria Francesca Moro & Mauro Giovanni Carta. (2014) Evaluating aripiprazole as a potential bipolar disorder therapy for adults. Expert Opinion on Investigational Drugs 23:12, pages 1713-1730.
Read now
Read now
Gul Eryilmaz, Gökben Hizli Sayar, Eylem Özten, Işil Göğcegöz Gül, Oğuz Karamustafalioğlu & Özgür Yorbik. (2014) Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients. International Journal of Psychiatry in Clinical Practice 18:4, pages 288-292.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller & Siegfried Kasper. (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry 14:3, pages 154-219.
Read now
Read now
Domingo Gonzalez, Markus Bienroth, Vivienne Curtis, Matthew Debenham, Stuart Jones, Didier Pitsi & Mohan George. (2013) Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current Medical Research and Opinion 29:3, pages 241-250.
Read now
Read now
Melanie Zupancic & Misty L Gonzalez. (2012) Aripiprazole in the acute and maintenance phase of bipolar I disorder. Therapeutics and Clinical Risk Management 8, pages 1-6.
Read now
Read now
Luiz Dratcu, Sotonte Bobmanuel, Wendy Davies, Alan Farmer, Mohan George, Tanvir Rana, Mala Singh & Martin Turner. (2012) A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. International Journal of Psychiatry in Clinical Practice 16:4, pages 244-258.
Read now
Read now
Andrea de Bartolomeis & Giulio Perugi. (2012) Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance. Expert Opinion on Pharmacotherapy 13:14, pages 2027-2036.
Read now
Read now
Roger S McIntyre, Jinju Yoon, Jeanette M Jerrell & Samantha S Liauw. (2011) Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence. Neuropsychiatric Disease and Treatment 7, pages 319-323.
Read now
Read now
Guy M. Goodwin, Mocrane Abbar, Thomas E. Schlaepfer, Heinz Grunze, Rasmus W. Licht, Frank Bellivier, Konstantinos N. Fountoulakis, Alfredo Carlo Altamura, William Pitchot, Hans Ågren, Edith Holsboer-Trachsler & Eduard Vieta. (2011) Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. Current Medical Research and Opinion 27:12, pages 2285-2299.
Read now
Read now
Articles from other publishers (25)
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
247
304
.
Teruhiko Higuchi, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi & Jun Ishigooka. (2021) Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study. International Journal of Bipolar Disorders 9:1.
Crossref
Crossref
Jean-Michel Azorin & Nicolas Simon. (2019) Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder. Drugs 79:15, pages 1657-1677.
Crossref
Crossref
Joseph R. Calabrese, Raymond Sanchez, Na Jin, Joan Amatniek, Kevin Cox, Brian Johnson, Pamela Perry, Peter Hertel, Pedro Such, Robert D. McQuade, Margaretta Nyilas & William H. Carson. (2018) Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. Journal of Affective Disorders 227, pages 649-656.
Crossref
Crossref
Arvin Hedayati. (2017) Caution in Co-administration of Aripiprazole and Lithium in Patients with Learning Disability. Women's Health 5:6.
Crossref
Crossref
Bahman Dieji, Ali Nazeri Astane, Omid Rezaie, Akbar Biglarian & Nasir Amanat. (2017) Comparison of the Efficacy of Risperidone and Aripiprazole in Combination with Sodium Valproate in Patients with Acute Manic or Mixed Episodes. Iranina Journal of Psychiatric Nursing 5:2, pages 52-59.
Crossref
Crossref
Alessandro Cuomo, Viktoriya L. Nikolova, Nefize Yalin, Danilo Arnone, Andrea Fagiolini & Allan H. Young. (2017) Pharmacological treatment of mixed states. CNS Spectrums 22:2, pages 186-195.
Crossref
Crossref
Massimiliano Buoli, Marta Serati & A. Carlo Altamura. (2014) Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. Journal of Affective Disorders 152-154, pages 12-18.
Crossref
Crossref
Giovani Missio, Doris Hupfeld Moreno, Fernando Fernandes, Danielle Soares Bio, Márcio Gehardt Soeiro-de-Souza, Domingos Rodrigues dos SantosJrJr, Denise Petresco David, Luis Felipe Costa, Frederico Navas Demétrio & Ricardo Alberto Moreno. (2013) The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole. Trials 14:1.
Crossref
Crossref
Ying Zhao, Nian Xiong, Yang Liu, Yanhong Zhou, Nuomin Li, Hong Qing & Zhicheng Lin. (2013) Human dopamine transporter gene: differential regulation of 18-kb haplotypes. Pharmacogenomics 14:12, pages 1481-1494.
Crossref
Crossref
Maria Dobrinas, Jacques Cornuz & Chin B. Eap. (2013) Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers. Pharmacogenetics and Genomics 23:5, pages 286-292.
Crossref
Crossref
David E. Kemp, Marc De Hert, Zia Rahman, Paula Fyans, James M. Eudicone, Sabrina V. Marler, Ross A. Baker & Berit X. Carlson. (2013) Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine. Journal of Affective Disorders 148:1, pages 84-91.
Crossref
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen & Michael Berk. (2012) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders 15:1, pages 1-44.
Crossref
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
89
154
.
Pierre Alexis Geoffroy, Bruno Etain, Chantal Henry & Frank Bellivier. (2012) Combination Therapy for Manic Phases: A Critical Review of a Common Practice. CNS Neuroscience & Therapeutics 18:12, pages 957-964.
Crossref
Crossref
Thomas Messer, Cordula Tiltscher & Max Schmauss. (2012) Meist lebenslange Rezidivprophylaxe erforderlich. DNP - Der Neurologe und Psychiater 13:11, pages 46-55.
Crossref
Crossref
D. W. Boulton, G. D. Kollia, S. Mallikaarjun & D. M. Kornhauser. (2012) Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole. Journal of Clinical Pharmacy and Therapeutics 37:5, pages 565-570.
Crossref
Crossref
Michael Gitlin & Mark A Frye. (2012) Maintenance therapies in bipolar disorders. Bipolar Disorders 14, pages 51-65.
Crossref
Crossref
Gin S Malhi, Danielle M Bargh, Roger McIntyre, Michael Gitlin, Mark A Frye, Michael Bauer & Michael Berk. (2012) Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder. Bipolar Disorders 14, pages 1-21.
Crossref
Crossref
Hyun-Ghang Jeong, Moon-Soo Lee, Young-Hoon Ko, Changsu Han & In-Kwa Jung. (2012) Combination Treatment With Aripiprazole and Valproic Acid for Acute Mania. Clinical Neuropharmacology 35:3, pages 97-102.
Crossref
Crossref
Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester‐Blokland & Ronald Marcus. (2012) Aripiprazole in combination with lamotrigine for the long‐term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double‐blind study (CN138‐392). Bipolar Disorders 14:1, pages 41-53.
Crossref
Crossref
Sohita Dhillon. (2012) Aripiprazole. Drugs 72:1, pages 133-162.
Crossref
Crossref
Rif S. El-Mallakh & Yonglin Gao. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
25
32
.
Ronald Marcus, Arif Khan, Linda Rollin, Beth Morris, Karen Timko, William Carson & Raymond Sanchez. (2011) Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disorders 13:2, pages 133-144.
Crossref
Crossref
Lakshmi N. Yatham. (2011) A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. Journal of Affective Disorders 128, pages S21-S28.
Crossref
Crossref